Get access to our exclusively curated how-to guides to help you navigate through the world of cybersecurity and its adversaries.
Lyell Immunopharma is a South San Francisco-based, publicly traded cell therapy company (LYEL). Their T cell reprogramming technology focuses on the mastery of T cells to cure patients with solid tumors. They apply proprietary genetic and epigenetic reprogramming technology platforms to address barriers present in solid tumors in order to develop new medicines with improved, durable, and potentially curative clinical outcomes.
Discover how to evaluate and select the right CNAPP for...
Read How To
Discover how Fidelis Network & Palo Alto PRISMA Access integrate...
Read How To
A practical buyer’s guide to choosing the right Network Detection...
Read How To
Discover how to secure hybrid cloud deployments, bridging cloud and...
Read How To
Learn to secure cloud-native applications with ease. Explore architecture, automation,...
Read How To
Learn to automate security controls in Kubernetes environments. Get insights...
Read How To
Navigate the network DLP challenge effectively. Learn about key features...
Read How To
Discover how to ensure a secure transition to cloud environments....
Read How To
This guide explains the asymmetry between attackers and defenders, highlighting...
Read How To
